Nutralife Biosciences Debt
NLBS Stock | USD 0.0001 0.00 0.00% |
Nutralife Biosciences' financial leverage is the degree to which the firm utilizes its fixed-income securities and uses equity to finance projects. Companies with high leverage are usually considered to be at financial risk. Nutralife Biosciences' financial risk is the risk to Nutralife Biosciences stockholders that is caused by an increase in debt. In other words, with a high degree of financial leverage come high-interest payments, which usually reduce Earnings Per Share (EPS).
Given that Nutralife Biosciences' debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Nutralife Biosciences is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Nutralife Biosciences to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Nutralife Biosciences is said to be less leveraged. If creditors hold a majority of Nutralife Biosciences' assets, the Company is said to be highly leveraged.
Nutralife |
Nutralife Biosciences Debt to Cash Allocation
Many companies such as Nutralife Biosciences, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
Nutralife Biosciences currently holds 10 K in liabilities. Nutralife Biosciences has a current ratio of 0.1, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Nutralife Biosciences until it has trouble settling it off, either with new capital or with free cash flow. So, Nutralife Biosciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Nutralife Biosciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Nutralife to invest in growth at high rates of return. When we think about Nutralife Biosciences' use of debt, we should always consider it together with cash and equity.Nutralife Biosciences Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Nutralife Biosciences' operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Nutralife Biosciences, which in turn will lower the firm's financial flexibility.Nutralife Biosciences Corporate Bonds Issued
Understaning Nutralife Biosciences Use of Financial Leverage
Nutralife Biosciences' financial leverage ratio measures its total debt position, including all of its outstanding liabilities, and compares it to Nutralife Biosciences' current equity. If creditors own a majority of Nutralife Biosciences' assets, the company is considered highly leveraged. Understanding the composition and structure of Nutralife Biosciences' outstanding bonds gives an idea of how risky it is and if it is worth investing in.
NutraLife BioSciences, Inc., together with its subsidiaries, engages in the development, manufacture, and distribution of nutraceutical, dietary, wellness, and cannabidiol products. NutraLife BioSciences, Inc. was incorporated in 2010 and is based in Coconut Creek, Florida. Nutralife Biosciences operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 12 people. Please read more on our technical analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Nutralife Pink Sheet Analysis
When running Nutralife Biosciences' price analysis, check to measure Nutralife Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nutralife Biosciences is operating at the current time. Most of Nutralife Biosciences' value examination focuses on studying past and present price action to predict the probability of Nutralife Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nutralife Biosciences' price. Additionally, you may evaluate how the addition of Nutralife Biosciences to your portfolios can decrease your overall portfolio volatility.
What is Financial Leverage?
Financial leverage is the use of borrowed money (debt) to finance the purchase of assets with the expectation that the income or capital gain from the new asset will exceed the cost of borrowing. In most cases, the debt provider will limit how much risk it is ready to take and indicate a limit on the extent of the leverage it will allow. In the case of asset-backed lending, the financial provider uses the assets as collateral until the borrower repays the loan. In the case of a cash flow loan, the general creditworthiness of the company is used to back the loan. The concept of leverage is common in the business world. It is mostly used to boost the returns on equity capital of a company, especially when the business is unable to increase its operating efficiency and returns on total investment. Because earnings on borrowing are higher than the interest payable on debt, the company's total earnings will increase, ultimately boosting stockholders' profits.Leverage and Capital Costs
The debt to equity ratio plays a role in the working average cost of capital (WACC). The overall interest on debt represents the break-even point that must be obtained to profitability in a given venture. Thus, WACC is essentially the average interest an organization owes on the capital it has borrowed for leverage. Let's say equity represents 60% of borrowed capital, and debt is 40%. This results in a financial leverage calculation of 40/60, or 0.6667. The organization owes 10% on all equity and 5% on all debt. That means that the weighted average cost of capital is (.4)(5) + (.6)(10) - or 8%. For every $10,000 borrowed, this organization will owe $800 in interest. Profit must be higher than 8% on the project to offset the cost of interest and justify this leverage.Benefits of Financial Leverage
Leverage provides the following benefits for companies:- Leverage is an essential tool a company's management can use to make the best financing and investment decisions.
- It provides a variety of financing sources by which the firm can achieve its target earnings.
- Leverage is also an essential technique in investing as it helps companies set a threshold for the expansion of business operations. For example, it can be used to recommend restrictions on business expansion once the projected return on additional investment is lower than the cost of debt.